These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38918235)

  • 1. A randomized, open-label two-period crossover pilot study to evaluate the relative bioavailability in the fed state of atovaquone-proguanil (Atoguanil™) versus atovaquone-proguanil hydrochloride (Malarone®) in healthy adult participants.
    Kuemmerle A; Gossen D; Marx MW; Lorch U; Szramowska M; Kumar A; Singh D; Singh S; Ramachandruni H; Thankachen B; Kore S; Gaaloul ME; Borghini-Fuhrer I; Chalon S
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; ():. PubMed ID: 38918235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.
    Na-Bangchang K; Manyando C; Ruengweerayut R; Kioy D; Mulenga M; Miller GB; Konsil J
    Eur J Clin Pharmacol; 2005 Sep; 61(8):573-82. PubMed ID: 16041597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unanticipated CNS Safety Signal in a Placebo-Controlled, Randomized Trial of Co-Administered Atovaquone-Proguanil and Amodiaquine.
    Chalon S; Chughlay MF; Abla N; Marie Tchouatieu A; Haouala A; Hutter B; Lorch U; Macintyre F
    Clin Pharmacol Ther; 2022 Apr; 111(4):867-877. PubMed ID: 34453327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.
    Looareesuwan S; Chulay JD; Canfield CJ; Hutchinson DB
    Am J Trop Med Hyg; 1999 Apr; 60(4):533-41. PubMed ID: 10348225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro interactions and in vivo efficacy of atovaquone and proguanil against Babesia gibsoni infection in dogs.
    Iguchi A; Matsuu A; Fujii Y; Ikadai H; Hikasa Y
    Vet Parasitol; 2013 Nov; 197(3-4):527-33. PubMed ID: 24075418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atovaquone oral bioavailability enhancement using electrospraying technology.
    Darade A; Pathak S; Sharma S; Patravale V
    Eur J Pharm Sci; 2018 Jan; 111():195-204. PubMed ID: 28974387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia.
    Sukwa TY; Mulenga M; Chisdaka N; Roskell NS; Scott TR
    Am J Trop Med Hyg; 1999 Apr; 60(4):521-5. PubMed ID: 10348223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of a pharmacokinetic interaction between atovaquone and proguanil.
    Gillotin C; Mamet JP; Veronese L
    Eur J Clin Pharmacol; 1999 Jun; 55(4):311-5. PubMed ID: 10424325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.
    Høgh B; Clarke PD; Camus D; Nothdurft HD; Overbosch D; Günther M; Joubert I; Kain KC; Shaw D; Roskell NS; Chulay JD;
    Lancet; 2000 Dec; 356(9245):1888-94. PubMed ID: 11130385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase 1, Randomized, Open-Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects.
    Albrecht D; Iwashima M; Dillon D; Harris S; Levy J
    Headache; 2020 Apr; 60(4):701-712. PubMed ID: 31985049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria.
    Nakato H; Vivancos R; Hunter PR
    J Antimicrob Chemother; 2007 Nov; 60(5):929-36. PubMed ID: 17848375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mefloquine for preventing malaria during travel to endemic areas.
    Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
    Blanshard A; Hine P
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru.
    Llanos-Cuentas A; Campos P; Clendenes M; Canfield CJ; Hutchinson DB
    Braz J Infect Dis; 2001 Apr; 5(2):67-72. PubMed ID: 11493411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of malarone in therapy of malaria tropica].
    Ziegler T; Schau A; Winkler C
    Med Klin (Munich); 2002 Aug; 97(8):455-8. PubMed ID: 12229244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STOP 101: A Phase 1, Randomized, Open-Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD
    Shrewsbury SB; Jeleva M; Satterly KH; Lickliter J; Hoekman J
    Headache; 2019 Mar; 59(3):394-409. PubMed ID: 30659611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro.
    Thapar MM; Gupta S; Spindler C; Wernsdorfer WH; Björkman A
    Trans R Soc Trop Med Hyg; 2003; 97(3):331-7. PubMed ID: 15228254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand.
    Looareesuwan S; Wilairatana P; Chalermarut K; Rattanapong Y; Canfield CJ; Hutchinson DB
    Am J Trop Med Hyg; 1999 Apr; 60(4):526-32. PubMed ID: 10348224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
    Stickles AM; Smilkstein MJ; Morrisey JM; Li Y; Forquer IP; Kelly JX; Pou S; Winter RW; Nilsen A; Vaidya AB; Riscoe MK
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4853-9. PubMed ID: 27270285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.